Table 6 Patient demographics and clinical characteristics

Number of patients (N)

124

Gender

44 M, 80 F

Age, years^a,b

38 (20–70)

Weight, kg^b

70.3 (45–111)

Disease duration, years^a,c

6.3 (2.2)

EDSS^a,c

4.8 (1.7)

Length of follow-up, years^c

4.2 (2.6)

Previous therapy^d

63 (50.8%)—beta interferons

31 (25.0%)—beta interferons and copaxone

14 (11.3%)—copaxone

16 (12.9%)—other medications/medicine combinations